TRENTON, N.J. (AP) — Johnson & Johnson and two other major drugmakers say they are collaborating in a global project aimed at getting patient tests of experimental drugs up and running more quickly and efficiently.
They are each contributing to a database of doctors, hospitals and clinics vetted to participate in the complex tests needed to determine whether an experimental medicine is effective and safe.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.